Merck moves to dismiss Humana's third amened complaint in US antitrust case over Zetia
MLex Summary: Merck moved to dismiss Humana’s US antitrust claims accusing it of entering into an illegal pay-for-delay agreement, which kept a generic version of the cholesterol drug Zetia out of...To view the full article, register now.
Already a subscriber? Click here to view full article